In the UK, a patient is not eligible for electronic issue if a clinically significant atypical alloantibody has every been detected in their plasma, so this would not be an issue (unless, of course, the patient switches hospitals, forgets to produce their antibody card and the antibody is no longer detectable, and then they are a candidate for an anamnestic response). However, am I correct in thinking that you are referring to an antibody directed against a low incidence antigen here John, where the antigen is almost certainly not going to be expressed on the screening red cells? If so, that is a slightly different situation, because you are much less likely to come across, for example, a unit that is both K+ and Wr(a+) (although, of course, it can happen) than one which is K+ and Jk(a+) (to use Donna's example). Even then though, there was a paper/editorial written some years ago now by George Garratty entitled something along the lines of "Do we need to worry about low incidence antigens" (I don't think that is by any means the correct title, but it was something like that) in which he showed amthematically that there was very little chance of a unit of blood expressing a low incidence antigen being given to a patient by electronic issue, who had an antibody directed against this same antigen, and it being strong enough to cause anything more than a minor delayed haemolytic transfusion reaction, resulting in a little jaundice and a requirement for re-transfusion as the red cells are removed from the circulation. If I can find the actual reference amongst the detrius on my desk here at home, I'll post it.